While the global economy has presented a rough road for many companies, Kendle International has managed not only to miss the potholes, but to pave its own way to growth.
A leading global clinical research company, Kendle recently opened a new operations center in the Special Economic Zone (SEZ) of the Ahmedabad-Gandhinagar Knowledge Corridor in India.
"Growth in India is a key component of our strategy and will be very important to the future of Kendle" says Stephen Cutler, senior vice president and chief operating officer. "Our expanded presence in Asia, and in India in particular, creates efficiencies in the clinical development process for our customers worldwide."
Founded in Cincinnati in 1981 by Candace Kendle and Chris Bergen, Kendle was also ranked a top clinical research organization (CRO) to work with in the 2010 CenterWatch European Investigative Site Survey. Kendle is the only CRO to be ranked consistently among the top three providers for each of the past four years in the annual U.S. and European site surveys conducted by CenterWatch, a leading publishing and information services company focusing on the clinical trials industry.
"Kendle's ability to forge strong and collaborative relationships with investigative sites across the globe is key to our ability to deliver studies more efficiently and cost effectively for our customers, which is increasingly important in today's environment," says Cutler.
The company reported net income of $1.2 million for the first quarter 2010 compared with net income of $886,000 for the first quarter 2009.
Source: Stephen Cutler, Kendle International
Writer: Val Prevish